CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project explores the potential of antiproton therapy in cancer treatment, leveraging its unique annihilation properties to enhance tumor targeting while minimizing damage to surrounding healthy tissue. It aims to establish the biological advantages of antiprotons through various experiments.
Over the last 5 decades particle beam cancer therapy has shown its potential advantages in targeting tumors in critical areas.
Multiple centers have been established around the world.
To date about 60,000 patients have been treated with protons and 4000 patients have received heavy ion treatments.
Despite the apparent success of these treatments a continued effort is necessary to provide the best possible therapeutic ratio – the ratio of the biological effective dose to the tumor compared to bio…
MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
